Product-information requirements for veterinary medicines

Clinical trials in human medicines

New guidance on the conduct of clinical trials during public health emergencies in the EU

Human medicines European public assessment report (EPAR): Simponi, golimumab, Date of authorisation: 01/10/2009, Revision: 54, Status: Authorised

Agenda - Ad hoc Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 5 March 2026

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 5 March 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 5 March 2026, 15:15 (CET) to 5 March 2026, 16:15 (CET)

Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 39, Status: Authorised

Plasma master file certificates

Human medicines European public assessment report (EPAR): mNexspike, COVID-19 mRNA vaccine, Date of authorisation: 12/02/2026, Status: Authorised

Human medicines European public assessment report (EPAR): Kefdensis, denosumab, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised